Cabaletta Bio
CABA
41 hedge funds and large institutions have $117M invested in Cabaletta Bio in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 5 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 40 → 41 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.76% less ownership
Funds ownership: 67.69% → 66.92% (-0.76%)
48% less capital invested
Capital invested by funds: $227M → $117M (-$110M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.1M |
| 2 |
BlackRock
New York
|
+$970K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$953K |
| 4 |
State Street
Boston,
Massachusetts
|
+$824K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$513K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$4.72M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$2.16M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.88M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$245K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$232K |
CABA Hedge Fund Activity: Q1 2020 in Review
41 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q1 2020, worth a combined $117M — down 48% from $227M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CABA positions and 5 closed out — a net gain of 1 holder — while 16 added to existing stakes and 13 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.1M. The largest seller was Deerfield Management, cutting an estimated $4.72M.
- 41 institutional investors held Cabaletta Bio (CABA) as of Q1 2020, up from 40 in Q4 2019.
- Funds reported $117M of Cabaletta Bio stock for Q1 2020, down 48% quarter-over-quarter.
- 6 funds opened new Cabaletta Bio positions in Q1 2020 and 5 closed out, a net change of +1 holder.
- The largest Cabaletta Bio buyer in Q1 2020 was Millennium Management, an estimated $2.1M added.
- The largest Cabaletta Bio seller in Q1 2020 was Deerfield Management, an estimated $4.72M sold.
Based on aggregated 13F filings for Q1 2020.